Cargando…
Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells
BACKGROUND: Radiotherapy is one of the main therapeutic approaches for non–small cell lung cancer (NSCLC). However, radioresistant cancer cells can eventually cause tumor relapse and even fatal metastasis. It is thought that radioresistance and metastasis could be potentially linked by epithelial-me...
Autores principales: | Yao, Yuan-Hu, Cui, Yan, Qiu, Xiang-Nan, Zhang, Long-Zhen, Zhang, Wei, Li, Hao, Yu, Jin-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897817/ https://www.ncbi.nlm.nih.gov/pubmed/27266881 http://dx.doi.org/10.1186/s40880-016-0113-3 |
Ejemplares similares
-
Activation of the LKB1-SIK1 signaling pathway inhibits the TGF-β-mediated epithelial-mesenchymal transition and apoptosis resistance of ovarian carcinoma cells
por: Hong, Bo, et al.
Publicado: (2018) -
LKB1 inhibits proliferation, metastasis and angiogenesis of thyroid cancer by upregulating SIK1
por: Kou, Bo, et al.
Publicado: (2022) -
Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila
por: Choi, Sekyu, et al.
Publicado: (2015) -
Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies
por: Qiao, Lili, et al.
Publicado: (2022) -
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020)